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Summary
Vy9/V62 cellsrepresent a fraction ofhumany/6 cells that is expanded after birth in the periphery,
carries markers of activated cells, and becomes a major populationin peripheral blood. We found
that these cells do not comprise a single population but actually represent two nested sets, the
smaller of which, specific for M}~obacterium tuberculosis-pulsed antigen-presenting cells (APC),
is contained in a larger set specific for an antigen found on the Molt-4 lymphoma. The larger
set, representing 40-80% of all blood y/6 cells, is comprised of cells bearing the Vy9/Cy1
chain. Cells in the smaller, included set have an additional requirement for V62 (and probably
for certain permissive junctional regions, since a very small percentage of Vy9/Vb2 cells do not
react against mycobacteria-pulsed APC). Optimal stimulation by mycobacteria is dependent on
the presence ofAPC, and is not restrictedby classical major histocompatibility complex molecules.
Some ofthe Vy9/V62 mycobacteria-specific clones are also stimulated by APC pulsed with different
bacteria, such as Listeria monocytogenes and Escherichia coli, indicating that the populationincludes
several different patterns of reactivity. These data establish a relationship in humans between
specificity and V7/V6 gene usage, and offer an explanation for the peripheral expansion of these
y/6 cells.
I
n peripheral blood of normal human donors, 50-70% of
y/6 cells carry a TCR usinga single set of V genes, namely
Vy9 and V62, and a single y constant region, the disulphide-
linked Cy1 (1-4). We had previously shown that such cells
constitute only a minor fraction ofy/6 cells in the postnatal
thymus (4) and suggested, therefore, that the overrepresen-
tation of the single V gene pair was not due to a chemical
pairing advantage but rather to selective expansion in the pe-
riphery. Suggestive evidence has recently come from Parker
et al. (5), who recently showed that Vy9/V62 cells express
CD45RO, a putative marker of activated cells (6), and that
with age, their number increases in the blood, but not in
the thymus.
There are two possibilities to explain the selective expan-
sion of Vy9/V62 cells. The first is that these cells are ex-
panded by stimulation with a large number of antigenic pep-
tidesin association with monomorphic restriction molecules,
in accordance with the model proposed by Davis and Bjorkman
(7), in which the TCRVencoded regions, corresponding to
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CDR1 and CDR2, preferentially interact with restriction
molecules, while the D, J, and N regions, corresponding to
CDR3, contact the antigenic peptide. In support of this view
are the rare y/6 cells that see CD1, TL, or Qa, which are
nonpolymorphic class I-like molecules (8-11).
The second possibility is that the Vy9/V62 cells may be
expanded by a limited but powerful set ofligands. These could
be oftwo sorts: an environmentally recurring antigen to which
the Vy9/V62 pair has a particular affinity, or a "superan-
tigen" of the type known to bind to particular Vs regardless
ofthe specificities encoded by the V(D)Jjunctional sequences,
such as some bacterial enterotoxins and the cellular antigen
Mls (12, 13).
To discriminate between the various possibilities, we ana-
lyzed the specificities expressed by a large panel of Vy9/V62
cells from adult peripheral blood. Here, we show that the
selective expansion is not due to recognition of a common
restriction element but rather by the recognition of two
powerful ligands. The first is an antigen expressedby the tumor
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1311-1322cell line Molt-4, which behaves like a superantigen in that
it is recognized by y/b cells expressing theTCR Vy9-Cy1
chain . The second is foundonAPCpulsed with various bac-
teria, and is recognized by most Vy9/Vb2 cells .
Materials and Methods
TCell Cloning .
￿
T cell clones were established from peripheral
blood of normal donors as reported (14) . y/b cells were isolated
using theFACS® (440; Becton Dickinson& Co., Mountain View,
CA) and pan anti-6 mAb 61 . In some cases, CD4 -CD8- cells
were sorted and later identified as y/b' . Cells were cloned by lim-
iting dilution usingPHA(lug/ml) (WellcomeLaboratories, Dart-
ford, UK), human rII,2 (100 U/ml ; (Hoffmann-La Roche, Nutley,
NJ), and irradiated PBMC (5 x 10 5/ml) . T cell clones were re-
stimulated periodically following the same protocol .
MonoclonalAntibodies andTumor CellLines.
￿
The followingmAbs
were used: bl (pan anti-b) (15),BMA032 (anti-TCRa(3) (16), TR66
(anti-CD3e) (17), SrCS1 (anti-V61-J1/3) (18), BB3 (anti-V62) (3),
TiyA (anti*y9) (1), 4A11(antiVy4, generated in our laboratory),
Leu-3a (anti-CD4) and Leu 2a (anti-CD8) (Becton Dickinson&
Co .) Na 1/34 (anti-CDla) (19), WM25 (anti-CDlb) (20), 1OC3
(anti-CDlc) (21),W6/32(anti-MHC class I) (American Type Cul-
ture Collection [ATCC], Rockville, MD), anti-l02-microglobulin
antiserum (kindly provided by Dr. Jim Kaufman, Basel Institute
for Immunology, Basel), L243 (anti-DR) (ATCC), B7.21 (anti-
DP) (kindly provided by Dr. John Trowsdale, ICRF,London) . The
following tumor cell lines were obtained from ATCC : Molt-4,
Jurkat, K562, U937, and Raji . OVCA 432 was kindly provided
by Dr. R. Knapp, Dana Farber Cancer Institute, Boston, MA .
Molt-4 variants that express high andlow levels ofCDla or CDlc
were kindly provided by Dr. Cesar Milstein, Cambridge, UK.
TCellAssays.
￿
Proliferation assays were performedusing 5 x
10°responder cells/well and 6,000 rad irradiated EBVB cells (3 x
1('/well) or 3,000 rad irradiatedPBMC (105/well) as APC. RhIL2
was added in culture at 5 U/ml . After48 h, 1 ttCi of ['Hlthymi-
dine (Amersham International, Amersham, UK) was added and
the cultures were harvested after an additional 18 h. T cell killing
of "Cr-labeled target cells was tested as described (22) .
Antigens. The following antigens were used : Mycobacterium
tuberculosis (MT)' H37RA (batch No. 722075; Difco Laboratories,
Detroit, MI); heat-killed Listeria monocytogenes strainEGD obtained
from ATCC, prepared as described (23) ; Escherichia coliJM109, kindly
provided by Dr. Lucia Mori, grown overnight, then heat killed
1 h at 60°C ; purified protein derivative (PPD) (Statens Serum In-
situt, Copenhagen) ; tetanus toxin (provided by Dr. G. Corradin,
University of Lausanne).
Fluorescence Analysis.
￿
Cell surface marker analysis wasperformed
using a FACScan® (Becton Dickinson&Co.) . Proliferating cells
were identified using forward and side scatter parameters. Dead
cells were excluded with propidium iodide staining.
Southern Analysis, cDNA Amputation, and Direct Sequencing.
Clones mentioned in Tables 1 and2 were analyzed forVy and VS
gene rearrangements by Southern blot as already reported (4) . In
TiyA' clones, the junctional segments of they and S genes were
amplified either from genomicDNA (clonesB.1, B.3,C.4) or from
cDNA and directly sequenced . 11 out of these 18 clones (C.9-17 .
1.6, 1.7) had not previously been analyzed by Southern blot (4) .
1 Abbreviations used in this paper . MT, Mycobacterium tuberculosis; PPD,
purified protein derivative; SEA, staphylococcal enterotoxin A.
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Total RNA was extractedfrom 5 x 106 cells as described (4) .
Single-stranded cDNA was synthesized from 1-5 jig totalRNA
using an oligo(dT) primer andMMLV reverse transcriptase. 1/20
of each cDNA sample was amplified using the following primers :
Vy9, 5'-TCATACAGTTCCTGGTGTCC-3' (173 bases upstream
to the Vy9 3' end) ; Cy, 5'-GTGTTTGTGAGCTGCAGCAGT3'
(28 bases downstream to the 5' end of the C-III axon, sharing an
identical sequence with Cyl andthe three majorCy2 alleles) ; VS2,
5'-AGGAAGACCCAAGGTAACACAA3' (173 bases upstream to
the VS2 3' end) ; CS, 5'-CTTCACCAGACAAGCGACAT3' (71
bases from the 5' end of theC-Iaxon) ; Jyl, 5'-CTTGGAAATGT
TGTATTCTTCC-3'; Jb3, 5'-AAGATCAACTCACGGGGCTC-3.
The latter twoprimers were used for genomicDNAsamples only.
The amplification of the VS expressed in clone F, was obtained
by means of the "anchored" PCR, as recently described by Loh
et al . (24) . The amplifications were done for 40 cycles (94°C, 1
min ; 55°C, 1.5 min ; and 72°C, 1.5 min) with 25 pmol of each
primer in 50 /Al reactions . PCR products were purified from low
melting agarose gel, and one-third of the final volume was used
directly for sequencing . Dideoxynucleotide termination sequencing
reactions were done with a modified T7 DNA polymerase (Se-
quenase 2.0 ; United States Biochemical Corp., Cleveland, OH) .
The primers used for sequencing were either "internal" VS2, JP,
Jbl primers (VS2, 5'-AAGATACTTGCACCATCAGAG-3; JP,
5'-AAGCTTTGTTCCGGGACCAA3; Jb1, 5'-ACTTGGTTCC-
ACAGTCACAC-3'), or the same Vy9 and VS2 primers used in
the amplifications ; in some casesboth strands were sequenced. 3-5
,ul of theDNA template was mixed with 5 pmol of primer, 2 /Al
of5x polymerase buffer, 1 jul DMSO, and denatured at 95'C for
5 min. The samples (10,u1 final volume) were then transferred on
ice. Labeling reactions were done with 2 1tl of labeling mix (1.5
p.M dGTP, dCTP, dTTP), 111 ofO.1M DTT, 0.6 ltl ofDMSO,
1 itl of cx-["S]dATP, and 2 ltl (2-3 U) of Sequenase . Termination
reactions were according to manufacturer's instructions . The se-
quencing reactionswere then analyzed by standard electrophoresis
and autoradiography.
Results
A Large Fraction ofRn'pheral Blood .y/b Cells RecognizeMolt-4
Lymphoma Cells. We generated a large panel ofy/bT cell
clones (78) from peripheral bloodby usingPHA as a poly-
clonal stimulator and tested the ability of these clones to lyse
different tumor target cells. This random set of clones ex-
pressed many different sorts of specificities. A few were al-
loreactive, recognizing specific human class II alleles (as tested
on various EBV cells), and a very small set specifically saw
other antigens. Forexample, one clonerecognizes all mouse
T cells. In addition, as reported by other authors (25, 26),
we found that many of the y/b clones, when tested soon
after in vitro restimulation, exert a non-MHC-restricted killing
against a variety of tumor targets, including K562, U937,
OVCA 432, Raji, Jurkat, and Molt-4 (Fig. 1 A) . When the
same clones were rested for 4-8 wk, they progressively lost
this nonspecific reactivity, however, most of them retained
the ability to lyse Molt-4 (Fig. 1 B) .
To investigate whether the y/b receptor is involved in
Molt-4 recognition, we performed antibody inhibition ex-
periments with 61 and TiyA mAbs, which recognize Cb-
and Vy9-encoded epitopes (1, 5) . Fig. 1C shows that these
mAbs completely abolishedMolt-4 killing by five Vy9-positiveclones. Similar results were obtained with all the Vy9+
clones tested . In some experiments, we also measured the
release of serine esterases, which appears to be specific for
the killing mediated by the TCR and not by a putative NK
receptor (27) . Serine esterases activity was detected in the su-
pernatant after triggering ofVy9/VS2 cells with Molt-4 (data
not shown) . Thus, both mAb inhibition and serine esterases
release indicate that TCR is involved in Molt-4 recognition .
In contrast to the anti-receptor antibodies, mAbs directed
to various structures on the target were ineffective (Fig. 1
D) . Neither anti-MHC antibodies (W6/32, L243, B7.21
mAbs), nor anti-(32-microglobulin antiserum, nor anti-CDla,
-b, and -c mAbs were able to block Molt-4 killing. In addi-
tion, Molt-4 variants that express low levels of CD1a and
CD1c were recognized and killed by rested clones (data not
shown) . These results suggest that the TCRs ofy/S cells
recognize a Molt-4 surface structure that is neither a classical
MHC molecule nor CD1 .
Recognition ofMolt-4 Is a Property ofCells Expressing the Vy9-
Cyl Chain. To assess the relationship between the large set
of cells recognizing Molt-4 and the set of cells expressing
Vy9/VS2, we isolated anew panel of 189 random y/S clones
from peripheral blood using PHA and tested them for the
reactivity with the Vy9-specific antibody TiyA, and for their
capacity to kill Molt-4 . None of the TiyA - clones tested
(60/60) and all but one TiyA+ clones (128/129) killed
Molt-4 . This finding indicates that the two characteristics
define one set of cells . In peripheral blood, almost all Vy9+
cells recognize Molt-4, a specificity not shared by Vy9 -
cells.
Since most peripheral Vy9+ cells also express VS2, we
asked whether recognition of Molt-4 required both V genes.
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Figure 1 .
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Killing of Molt-4 cells by
vested .y/6 clones is efficient and is in-
hibitedby anti-TCR.y/6 mAbs . Molt-4
cells are killed with high efficiency by
both freshly restimulated (A) and rested
clones (B) . Targets : Molt 4 (" ), Jurkat
(O), K562 ("), Raji (A) . (C) Addi-
tion of anti-CD3 (TR66) (O), anti-6
(61) (/), and antiV y9 (Ti-yA) (A)
mAbs completely abolished killing of
Molt-4 (") . (D) Addition of anti-02-
microglobulin antiserum (O), anti-DR
(L243) (" ), anti-DP (B7.21) (A), anti-
MHC class I mAb (W6/32) (" ), and
anti-CD1c (1) mAbs do not inhibit
killing of Molt-4 (") .
We selected from our collection of y/S clones (4) those ex-
pressing "unusual" pairings ofVy and V8 chains, and mea-
sured their reactivity to Molt-4 . Table 1 shows 41 y/b clones,
classified according to the expression of V-y9, V62, and the
Cy1 vs . the Cy2 isotypes (i .e ., the disulphide- or non-
disulphide-linked constant region heterodimer) . Although the
number of clones is small, and two out of the possible eight
combinations are missing, the following conclusions can be
made : (a) killing ofMolt-4 requires both Vy9 and Cyl, but
does not requireVS2 ; and (b) expression ofVy9/Cyl, though
necessary, is not sufficient since one Vy9+ clone (E13) kills
K562 (data not shown) but does not kill Molt-4 .
Thus, Molt-4, like the well-known superantigens, is rec-
ognized by nearly all cells expressing a single particular V
gene, though in the case of 'r/6 cells, an additional require-
ment exists for the disulphide-linked form of the constant
region .
Stimulation ofPBMC withM. tuberculosis Leads to the Selec-
tive Expansion ofVy9/Va2 Cells. It has recently been reported
that a large number ofhuman y/6 cells proliferate in response
to mycobacterial lysates (29) . To characterize theTCR ofthese
cells, we stimulated PBMC with heat-killed MT. Cells from
six different donors proliferated vigorously to MT. The
proliferating cells were identified by FACS® as large cells with
forward and side scatter parameters and analyzed with a panel
of mAbs specific for human Vy or VS chains (Fig . 2 A) .
In five of six donors, there was a striking increase of y/b
cells, identified as b+ (with the mAb bl) and oi/f3 - (with
BMA032), from 1-5% at day 0, to 40-90% at day 14 . The
proliferating y/S cells also stained with anti-V62 (BB3) and
antiVy9 (TiyA) mAbs, while they did not react with anti-
V31 (8TCS1), nor with antiVy4 (4A11) mAbs, indicating
uu -
75
50
25
nTable 1 .
￿
Correlation of TCR-y/6, MT, and Molt-4 Recognition
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continued
A. PHA-derived clones
Name Vy
Vy9'Cyl/V&2`
V& &1 &TCS1
mAb reactivity
BB3 Ti7A 4A11 MT
Reactivity
Molt-4
A.1 Vy9JP V&2J1 + - + + - + +
A.2 Vy9JP V&2J1 + - + + - +
B .1 Vy9J1 V&2J1 + - + + - + +
B.2 Vy9JP V&2Jl + - + + - + +
B.3 Vy9JP V&2J3 + - + + - + +
B .4 Vy9JP V&2J1 + - + + - + +
C.1 Vy9JP V&2J1 + - + + - + +
C.2 Vy9JP V&2J1 + - + + - +
C.3 Vy9JP V&2J1 + - + + - - +
C.4 Vy9JP V&2J3 + - + + - + +
E.1 Vy9JP V&2J1 + - + + - + +
E.3 Vy9JP V&2J3 + - + + - + +
E .5 Vy9JP V&2J1 + - + + - + +
1.3 Vy9JP V&2J3 + - + + - +
1.6 Vy9JP V62J1 + - + + - -
1.7 Vy9JP V&2J3 + - + + - -
Vy9'Cy1/V&2 -
E.13 Vy9JP V&5J1 + - - + - -
F.3 Vy9JP1 V&1J1 + + - + - - +
G.1 Vy9J1 V&1J1 + + - + - +
Vy9*/V&2-
D.2 Vy9J2 V&1J1 + + - + - - +
E.2 Vy9J2 V&7J1 + - - + - - +
E.6 Vy9J2 V&8J1 + - - + - - -
E.9 Vy9J2 V&1J1 + + - + - - +
F.1 Vy9J2 V&5J1 + - - + - - -
F.7 Vy9J2 V&1J2 + + - + - - -
G.2 Vy9JP2 V&1J1 + + - + - -
E.4 Vy9J2 V61J1 + + - + - -
E.19 + - - + - -
Vy9 -Cyl/V&2 -
A.4 Vy5J1 V&1J1 + +
A.10 Vy8JPl V61J1 + +
Vy9'Cy2/V&2
E.11 Vy2J1/2 V&2J3 + - + - -
E.15 Vy4J2 V&2J3 + - + - +
Vy9'Cy2/V62 -
A.11 Vy4J2 V&3J1 + - - - +
B.7 Vy2/8J2 V&1J2 + - - - -
C.5 VyxjP2 V&1J1 + + - - -
C.6 Vy3/10J2 V&lJi + + - - -The clones were derived from peripheral blood or postnatal thymus as specified in reference 4 . TheVy andV6 genes arenamed according to references
4 and 28 except for V67, which is a newV gene, and V68, which has already been reported in a TCR tx chain (N. Migone, et al ., manuscript
in preparation). Blanks are not done.
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Figure 2 . Stimulation of PBMC
with MT induces proliferation of
Vy9/V62cells .PBMC were stimulated
with 50 P.g/ml ofMT strain H37RA,
PPD (10 ug/ml), tetanus toxoid (20
hg/ml), or 30 U/ml of IL2. After 4
d, 10 U/ml of IL2 was added to the
cultures, and at days 7 and 15 of cul-
ture, proliferating cells were analyzed
forreactivitywithCD3 ("), TCR-ot/f
(O), C6 (!]),Vy9(+),Vy4 (*), V62
(" ), andV61(A) -specificmAbs. (")
y/6 cells withVyregions different from
Vy4 and Vy9, and (1) cells with VSs
other than V61andV62. All the donors
days of culture
￿
were tuberculin skin test positive.
1315
￿
De Libero et al .
Table
Name
1 . (continued)
A. PHA-derived clones
Vy VS 61 STCS1
mAb reactivity
BB3 TiyA 4A11 MT
Reactivity
Molt-4
C.7 Vy8JP2 V61J1 + + - - -
C.8 Vy4J2 V63J1 + - - - +
D .1 Vy2/8J2 V61J1 + + - - -
A.5 Vy4J2 V61J1 + + - - +
E.16 Vy4J2 VS3J3 + - - - +
B . Clones derived from
MT-specific cell lines
C.10 Vy9JP V62J1 + - + + - + +
C.11 Vy9JP V62J1 + - + + - + +
C.12 Vy9JP V62J1 + - + + - + +
C.13 Vy9JP V62J1 + - + + - + +
C.15 Vy9JP V62J1 + - + + - + +
C.16 Vy9JP VS2J1 + - + + - + +
C.17 Vy9JP V62J1 + - + + - + +
C.18 + - + + - + +
C.19 + - + + - + +
C.20 + - + + - +
C.21 + - + + - +
C.22 + - + + - +
C.23 + - + + - +
Q.1 + - + + - +
Q.2 + - + + - +
Q.3 + - + + - +
C.9 Vy9JP V62J1 + - + + - - ±
C.24 + - + + - - +
Q.4 + - + + - -that virtually all the y/S cells carried a Vy9/V62 receptor
(data not shown) .
PBMC from the same donors did not show a preferential
expansion of y/6 cells when stimulated with PPD, tetanus
toxin, or 30 U/ml of IL -2 (Fig . 2, B-D) . These results indi-
cate that only stimulation with mycobacteria and not with
PPD or other protein antigens specifically activates Vy9/VS2
cells in PBMC .
The proliferating T cells fromMT cultures were expanded
in IL2 and tested for their response to MT The cell lines
proliferated in response to MT but not to PPD or tetanus
toxoid (data not shown) . They also killed mycobacteria-pulsed
APC (data not shown) . Thus, the response to MT is selec-
tively comprised of y/S cells bearing Vy9/VS2 .
Recognition ofMolt-4 andM . tuberculosis Are Properties ofOver-
lapping Sets ofy1b T Cells. Since Vy9 is associated with
recognition of Molt-4, the finding that Vy9/VS2 characterizes
y/S cultures specific for MT led us to ascertain whether the
two specificities are associated with separate or overlapping
sets ofT cells. We therefore generated a set of clones from
cultures responding to MT and analyzed their TCR usage
and their specificity to various antigens. Table 1 shows a com-
parison ofthese clones with a set ofrandomly derived clones
from peripheral blood .
Every clone derived fromMTspecific cell lines reacts with
BB3 and TiyA mAbs and therefore expresses a Vy9/VS2
TCR (Table 1B) . Furthermore, all the clones that were tested
express the disulphide-linked V79-JP-Cy1/VS2J1 receptor,
Table 2.
￿
TCR-y Sequences
1316 Antigen Specificities of V-y9/VS2 Cells
and lyse Molt-4 targets . The molecular analysis thus confirmed
that the receptor ofMTreactive clones is Vy9/VS2 .
In the sample of randomly derived clones (Table 1 A), 11
of 23 of the Vy9+, and 11 of 14 of the Vy9/VS2-tested
clones proliferated to MT-pulsed APC, whereas none of the
clones bearing other TCR combinations showed any prolifer-
ative responses to this bacterium .
Thus, the clones specific forMT appear to comprise a major
proportion of the set specific for Molt-4 . However, unlike
the Molt-4 specificity, which appears to be dictated solely
by the Vy9-Cy1 chain, reactivity toMT requires the addi-
tional component of VS2 .
Because -20% ofVy9/VS2 tested cells do not react with
MT, we asked whether any particular N, D, or J segment
correlated with this specificity by sequencing the junctional
regions of Vy9/VS2 clones belonging both to MT-reactive
and nonreactive groups . The results showed that the exam-
ined TCRs have different y (Table 2) and S (Table 3) func-
tional sequences, with no obvious consensus amino acid se-
quences or lengths (Table 4) that might distinguish between
the two groups of cells . Two clones (1.7, which does not re-
spond to MT, andC.15, which does respond to this stimula-
tion) have an identicalVy9 chain but different Vbs, suggesting
that they chain alone does not confer the specificity and also
that the S chain is important . Thus, while Molt-4 behaves
like a cellular superantigen, specificity for MT has features
more closely resembling specificity to normal antigens. The
characteristics summarized in Tables 2-4 evoke comparisons
Clone
MT
reactivity V-y9 TTG
Germ line
TGG GAG GTG N
T
G
GGG
AAT
CAA
TAT
GAG
TAT
TTG
AAG
GGC
AAA
JP
J1/2
F .1 - TTG TGG GAG GTG CAGGC G AAA 2
1 .7 - TTG TGG GAG G CT CAA GAG TTG GGC P
C .3 - TTG TGG G GTCTGATG GAG TTG GGC P
1.6 - TTG TGG GAG GTG CCTGGGGGG GAG TTG GGC P
C .9 - TTG TTG GAG GTG CACGATTTGGG G TTG GGC P
C.10 + TTG TGG GAG G ACAA G CAA GAG TTG GGC P
C.11 + TTG TGG G GGC GG CAA GAG TTG GGC P
C.12 + TTG TGG GAG GTG CGC GAG TTG GGC P
C.13 + TTG TGG GAG GTG CTCCG A GAG TTG GGC P
C.14 + TTG TGG ATTGTC CAA GAG TTG GGC P
C.15 + TTG TGG GAG G C G CAA GAG TTG GGC P
C.16 + TTG TGG GAG GTG CTT CAA GAG TTG GGC P
C.17 + TTG TGG GAG GTG GTG GAG TTG GGC P
C.1 + TTG TGG GAG G CCCCC GGG CAA GAG TTG GGC P
A.1 + TTG TGG GAG G ACCTCCC G TTG GGC P
C.4 + TTG TGG GAG GTG CGGC AA GAG TTG GGC P
B.3 + TTG TGG G TT GGG CAA GAG TTG GGC P
B.1 + TTG TGG GAG GT A AAG AAA 1w ro
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with, for example, the response to cytochrome c in mice, where
T cell clones of one particular functional phenotype always
express the identical Vcx and Vii combination, but vary at
junctional regions (30) .
Characteristics ofthe Response toM. tuberculosis.
￿
To analyze
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the biology of the response to MT, we began with the ques-
tion of MHC restriction . We first asked whether the y/S
clones showed any preference for antigen in the context of
polymorphic MHC molecules using EBVB cells bearing
different HLA haplotypes as APC. Fig . 3 shows that all tested
Figure 3 .
￿
Vy9/VS2 cells are not re-
stricted by classicalMHC molecules .
y/S clones were stimulated with MT
(50A .g/ml) andEBVB cell lines asAPC
displaying different HLA class I and
class II haplotypes. AL Tls : A2,26 ;
Bw49,58 ; DR6, DPI ; BSM : A2,
Bw62, Cw3, DR4, DQw3, DP2 ;
KT11 : Aw33, Bw44, Cw3, DR3, 6,
DQwl,DP2, 4;EKR : A3, B7, DR7,
DQw2 ; OOS : A26, Bw56, Cw2,
DRl, DQwl,DP2 . Similar results were
obtained with 19otherVy9/VS2 clones
from different donors.
Table 4. Deduced Amino Acid Sequences Encoded by VJ y and V-DJ &Junctions
MT
Clone reactivity Vy N Jy VS N-(D)-N JS
F.1 - ALWEV OA KL CAA TTNCRSGGAY TDKL
1.7 - ALWE A QELG CDT PGIGYT WDTR
C.3 - ALW GLM ELG CDT VGSLLGDTE L
1 .6 - ALWEV PGG ELG CDT LPLGDRDT DKL
C.9 - ALWEV HDLG LG CDT VSTGGYGSSPPRG DKL
C.10 + ALWE DK QELG CD IVGGIRWGP DKL
C.11 + ALW GR QELG CD PVLGDTLAA DKL
C.12 + ALWEV R ELG CDT LOAGGP TDKL
C.13 + ALWEV LR ELG CD DLTLLGGKND TDKL
C.14 + ALW IV QELG CD LLGVLH TDKL
C.15 + ALWE A QELG CDT LGSGGSAER TDKL
C.16 + ALWEV L QELG CD AVGTN TDKL
C.17 + ALWEV VO LG CD IVKTGGLEY TDKL
C.1 + ALWE AP GQELG CDT LIH TDKL
A.1 + ALWE DLP LG CDT VSLTGGL TDKL
C.4 + ALWEV R QELG CD PAILGDEL SWDTR
B.3 + ALW V GQELG CD PVLGDTPNP SWDTR
B .1 + ALWEV KKL CD SVDKPR TDKLFigure4.
￿
APC are required for optimal stimulation ofVy9/VS2 clones
by MT y/b clones were stimulated with MT (50,ug/ml) in the absence
or in thepresence of variousAPC and tested in a proliferation assay . Similar
results were obtained with 19 otherVy9/VS2 clones from different donors.
EBVB cells, irrespective ofMHC type, functioned as APC
for MTreactive y/b clones, suggesting that polymorphic
MHC determinants are not involved in the stimulation of
they/b clones . We also attempted to identify any nonpoly-
morphic restriction molecules by mAb inhibition using mAbs
specific for framework regions of class I molecules (W6/32),
as well as anti-a2-microglobulin antisera, anti-DR, and anti-
DPmAbs. Although these antibodies consistently block an-
tigen recognition by TCR-ci/a+ cells (data not shown), we
failed to detect consistent inhibition of y/b cell proliferative
responses or lysis of mycobacteria-pulsed target cells (data not
shown) .
Having found no special role for APC of any particular
haplotype, we asked whether APC are needed at all . Fig . 4
shows that T cells give a low response toMT alone, while
they proliferate well when bothEBVB cells and antigen are
present . These findings indicate that APC are indeed required
for maximum stimulation ofy/b cells, although selfpresen-
tation by theT cells themselves may occur. Both PBMC (data
not shown) and EBVB cells functioned as APC, while a T
cell line Gurkat) did not . Thus, the bacterial antigens, like
conventional antigens presented to CD4 or CD8 T cells, re-
quire the presence ofAPC for optimal activation of y/b T
cells . Whether this is due to a more efficient processing, or
presentation by APC, is under investigation.
To study the antigen specificity of y/b clones, we used
APC pulsed with different bacteria such as MT, L . mono-
cytogenes, orE. coli . Interestingly, (Table 5) somey/b clones,
originally raised against MT, were also activated by APC pulsed
with different bacteria, suggesting that the different bacteria
might share common antigens or might induce the expres-
sion of similar determinants on the APC surface.
In summary, these results indicate that : (a) optimal stimu-
lation of y/b cells requires the presence ofAPC ; (b) y/b clones
are not restricted by classical (class I or II) or nonclassical
(class I-like)MHC molecules ; and (c) some y/6 clones recog-
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Table 5 .
￿
Vy9/V62 Clones Recognize APC Pulsed with
Different Bacteria
Cell proliferation was assessed in the presence or absence ofAPC (3 x
104 EBV-B/well) with the addition of 5 U/ml of IL-2 .
' The results are expressed as mean cpm x 10-3of triplicates . Irradiat-
ed APC gave a [3H]Thy incorporation of 15.4 x 103 cpm .
nize APC pulsed with different bacteria, suggesting that
bacteria-pulsed APC display common structures.
Discussion
Our results indicate that a large fraction ofhuman periph-
eral blood y/b cells is able to recognize Molt-4 as well as
bacteria-pulsed APC . While these two "superspecificities"
are both found within the Vy9/VS2 population, which is
the most abundant y/b subset in peripheral blood, the two
sets are not precisely overlapping and can be defined as follows.
The major set of peripheral y/bT cells, those that recog-
nize Molt-4, is comprised ofclones bearing a disulphide-linked
Vy9-bearing receptor. TheVS chain seems to be less critical,
since at least two different Vbs can pair with Vy9-Cy1 chains
in Molt-4-reactive clones. Thus, the recognition of Molt-4
by human Vy9+ cells resembles the recognition of Mls
ligands by mouseT cells expressing particular V,3 gene prod-
ucts (13) . In both cases, the structure of the second TCR
chain and ofN, D, orJ regions seems to be largely irrelevant .
The molecular nature of the Molt-4 associated and Mls
Clone APC - MT
Bacteria
L. monocytogenes E. coli
A.1 - 0.4" 0.7 0.4 0.5
+ 14 36.6 28.4 19.8
R.4 - 12.2 15.5 7.2 7.3
+ 21 .5 85.2 48.1 25.8
R.13 - 6.7 5.9 5.1 8.9
+ 14.6 72.8 32.6 12.9
R.16 - 6.6 18.2 4.1 8.2
+ 16.8 70.3 47.8 47.4
R.23 - 5 16.5 2.7 9.5
+ 15 .5 87.1 54.5 23.4
R.61 - 1 .9 34.3 10.3 10.8
+ 16 104.2 35.2 26.5
R.64 - 1 .2 29.3 8.2 17.7
+ 17.9 120.6 37.5 50.5
R.65 - 1 .1 16.8 5.6 9.3
+ 23 .6 82.3 45.7 23.9
R.67 - 2 .7 14.4 10.4 10.1
+ 16.8 67.9 42.5 22.8
R.74 - 5.1 42 .2 6.1 11.7
+ 18.9 113 .5 43.4 47.5gene-controlled superantigens remains to be elucidated . Re-
cently, Vy9-related ligands have also been found to be ex-
pressed by Daudi cells (31) and by staphylococcal enterotoxin
A (SEA) (32) . It is possible that cellular superantigens iden-
tical or related to the Molt-4 and Daudi superantigens, or
microbial superantigens like SEA, might play a role in the
expansion of a subset ofVy9+ cells in the periphery. How-
ever, this mechanism cannot explain the preferential use of
V62 by the vast majority of circulating Vy9+ cells .
The second superspecificity, directed against mycobacteria-
pulsed APC, is found in 80% of peripheral bloodVy9/V62
cells. This reactivity is dependent on the expression ofVy9
and V62, though the expression ofboth these gene segments
is not completely sufficient, since -20% ofVy9+/V62+-
tested clones do not recognize mycobacteria-pulsed APC. It
is not yet clear whether the lack of reactivity is due to the
presence ofinappropriateTCRjunctional regions or to other
reasons .
The Vy9/V62 TCR of the mycobacteria-reactive cells ex-
hibit extensivejunctional diversity. In the context ofthe model
proposed by Davis and Bjorkman (7), we might interpret
our data to indicate that the mycobacteria-reactive y/6 TCRs
contact a monomorphic restriction molecule with Vy9- and
V62-encoded regions and an antigenic determinant using
regions encoded by the junctional sequences. However, we
found no evidence that any knownMHC class II, nor any
known or unknown 02-microglobulin-associated class I,
molecule acted as restriction elements for either of the two
major specificities .
In spite of the lack ofMHC restriction, we found that
APC were required for optimal proliferation of ylb cells . We
also found that some y/6 clones, originally raised with MT,
also recognize APC pulsed with different bacteria, such as
L . monocytogenes and E . coli .
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